Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AURA Aura Biosciences
11.900-0.210-1.73%
Trading Session
02/08 10:58 ET
High
12.080
Open
12.080
Turnover
80.21K
Low
11.738
Pre Close
12.110
Volume
6.73K
Intraday
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Chiesi Ventures Cuts Stake in Aura Biosciences
Aura Biosciences, Inc. (NASDAQ:AURA) Short Interest Up 38.7% in December
Aura Biosciences, Inc. (NASDAQ:AURA – Get Rating) was the recipient of a large growth in short interest during the month of December. As of December 30th, there was short interest totalling 688,300 s
Short Interest in Aura Biosciences, Inc. (NASDAQ:AURA) Drops By 53.2%
Aura Biosciences, Inc. (NASDAQ:AURA – Get Rating) was the recipient of a significant drop in short interest during the month of December. As of December 15th, there was short interest totalling 496,4
Institutional Investors May Adopt Severe Steps After Aura Biosciences, Inc.'s (NASDAQ:AURA) Latest 11% Drop Adds to a Year Losses
Insider Buying: Aura Biosciences, Inc. (NASDAQ:AURA) Director Purchases $123,700.00 in Stock
Aura Biosciences, Inc. (NASDAQ:AURA – Get Rating) Director David Michael Johnson bought 10,000 shares of Aura Biosciences stock in a transaction that occurred on Thursday, December 1st. The stock was
Matrix Capital Management Comp Purchases 1,250,000 Shares of Aura Biosciences, Inc. (NASDAQ:AURA) Stock
Aura Biosciences, Inc. (NASDAQ:AURA – Get Rating) major shareholder Matrix Capital Management Comp purchased 1,250,000 shares of Aura Biosciences stock in a transaction on Monday, December 5th. The s
$49.5 Million Bet On Howard Hughes? Check Out These 4 Stocks Insiders Are Buying
Although US stocks closed mostly lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view
We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although Amazon.com made losses for many years after l
Aura Biosciences Shares Drop 19% After Public Offering Prices
By Chris Wack Aura Biosciences Inc. shares were down 19% to $11.63 Thursday after the biotechnology company said it priced an underwritten public offering of 6.7 million common shares at $12 each. T
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersOtonomy (NASDAQ:OTIC) shares increased by 19.1% to $0.21 during Thursday's pre-market session. The company's market cap stands at $12.2 million. Sigilon Therapeutics (NASDAQ:SGTX) stock moved u
Company Overview
More
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.
CEO： Ms. Elisabet de los Pinos
Market： NASDAQ
Listing Date： 10/29/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet